OUR STORE IS CLOSED ON ANZAC DAY: THURSDAY 25 APRIL

Close Notification

Your cart does not contain any items

$179

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
CRC Press
19 November 2019
Peritoneal malignancy is a rapidly growing field within surgical oncology. National and International treatment programmes and training curricula are being established worldwide to co-ordinate treatment and management of these challenging clinical problems. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. The Peritoneal Malignancy Institute in Basingstoke, the largest centre in the world, is at the forefront of new developments and techniques. This manual combines the experience of the PMI with the latest evidence to provide a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.

Edited by:   , , , , , ,
Imprint:   CRC Press
Country of Publication:   United Kingdom
Dimensions:   Height: 246mm,  Width: 189mm, 
Weight:   458g
ISBN:   9781138495111
ISBN 10:   1138495115
Pages:   214
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A ‘paradigm’ for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.

Tom Cecil is Clinical Director at the Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals NHS Foundation Trust and Honorary Transplant Surgeon, Oxford University Hospitals, Oxford, UK. John Bunni is a Consultant Colorectal and General Surgeon, Royal United Hospital, Bath, UK. He is also Visiting Lecturer, University of Bath, UK; Honorary Lecturer, Cardiff University, UK and was awarded the ASGBI Gold Medal. Akash Mehta is Consultant Colorectal Surgeon at St Mark’s Hospital & Academic Institute, London, UK and holds the ESSO European Certification in Peritoneal Surface Oncology.

See Also